Wave Life Sciences Ltd.WVENASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average, slight contraction.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-3.23%
↑ 99% above average
Average (39q)
-575.49%
Historical baseline
Range
High:138.30%
Low:-22205.26%
CAGR
-5.7%
Structural decline
| Period | Value |
|---|---|
| Q3 2025 | -3.23% |
| Q2 2025 | -6.90% |
| Q1 2025 | -261.11% |
| Q4 2024 | 138.30% |
| Q3 2024 | -88.00% |
| Q2 2024 | -4.17% |
| Q1 2024 | -60.00% |
| Q4 2023 | -327.27% |
| Q3 2023 | 133.00% |
| Q2 2023 | 16.67% |
| Q1 2023 | 48.94% |
| Q4 2022 | -11.90% |
| Q3 2022 | -22205.26% |
| Q2 2022 | 100.31% |
| Q1 2022 | -1.64% |
| Q4 2021 | -408.33% |
| Q3 2021 | 84.62% |
| Q2 2021 | 9.30% |
| Q1 2021 | -45.76% |
| Q4 2020 | 31.40% |
| Q3 2020 | 25.22% |
| Q2 2020 | 16.67% |
| Q1 2020 | 16.36% |
| Q4 2019 | -11.49% |
| Q3 2019 | -21.31% |
| Q2 2019 | 10.29% |
| Q1 2019 | -17.24% |
| Q4 2018 | 9.38% |
| Q3 2018 | -4.07% |
| Q2 2018 | 2.38% |
| Q1 2018 | -15.60% |
| Q4 2017 | -15.96% |
| Q3 2017 | -2.17% |
| Q2 2017 | -3.37% |
| Q1 2017 | -12.66% |
| Q4 2016 | -5.33% |
| Q3 2016 | -47.06% |
| Q2 2016 | -41.67% |
| Q1 2016 | -9.09% |
| Q4 2015 | -32.00% |